Correspondence
Re: Lanvers C et al. Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia. Med Pediatr Oncol 2003;40:293–301†
Franca Formelli,
Corresponding Author
Franca Formelli
Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy.===
Search for more papers by this author
Franca Formelli,
Corresponding Author
Franca Formelli
Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy.===
Search for more papers by this author
First published: 17 December 2003
No abstract is available for this article.
REFERENCES
- 1
Lanvers C,
Reinhardt D,
Dubbers A, et al.
Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia.
Med Pediatr Oncol
2003;
40:
293–301.
- 2
Jacobson DM,
Berg R,
Wall M, et al.
Serum vitamin A concentration is elevated in idiopathic intracranial hypertension.
Neurology
1999;
53:
1114–1118.
- 3
Berni R,
Clerici M,
Malpeli G, et al.
Retinoids: In vitro interaction with retinol-binding protein and influence on plasma retinol.
FASEB J
1993;
7:
1179–1184.
- 4
Barua AB,
Duitsman PK,
Kostic D, et al.
Reduction of serum retinol levels following a single oral dose of all-trans retinoic acid in humans.
Int J Vitam Nutr Res
1997;
67:
423–426.
- 5
Formelli F,
Carsana R,
Costa A, et al.
Plasma retinol level reduction by the synthetic retinoid fenretinide: A one year follow-up study of breast cancer patients.
Cancer Res
1989;
49:
6149–6152.
- 6
Garaventa A,
Luksch R,
Piccolo MS, et al.
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.
Clin Cancer Res
2003;
9:
2032–2039.
- 7
Takahashi N,
Sausville EA,
Breitman TR.
N-(4-hydroxyphenyl)retinamide (fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
Clin Cancer Res
1995;
1:
637–642.
- 8
Formelli F,
Cleris L.
Therapeutic effects of the combination of fenretinide and all-trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin-resistant sub-line.
Eur J Cancer
2000;
36:
2411–2419.
